Skip to content

HairDx Analytical Validation Study

HairDx Analytical Validation Study

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04379583
Enrollment
0
Registered
2020-05-07
Start date
2020-06-15
Completion date
2021-12-06
Last updated
2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenetic Alopecia, Female Pattern Baldness, Hair Loss, Hair Loss/Baldness

Brief summary

The HairDx Test reports genetic variants associated with the development of FPHL.

Detailed description

The HairDx Test reports genetic variants associated with the development of FPHL. The variants are detected from a saliva sample collected at home. The HairDx Test report is designed to help individuals understand the meaning of their results and encourage a conversation with a healthcare professional. The information provided by the HairDx Test report is not intended to start, stop or change any course of treatment. The purpose of this study is to collect DNA samples from subjects. The DNA samples will be used for the analytical validation of the HairDx Test. The results of this study will not be shared with the subjects.

Interventions

DEVICEHairDx Sample Collection Kit

Saliva collection using FDA OTC cleared sample collection device

Sponsors

Applied Biology, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum

Inclusion criteria

* Females over the age of 18 * Overall good health * Able to give informed consent * Willing to collect saliva sample

Exclusion criteria

* Xerostomia (dry mouth) * Inability to provide informed consent in English * Inability to follow instructions for saliva sample collection * Non US resident

Design outcomes

Primary

MeasureTime frameDescription
Determination of the accuracy of the HairDx TestBaselineDetermination of the accuracy of the HairDx Test in comparison to bi-directional Sanger sequencing
Determination of the precision and reproducibility of HairDx TestBaselineDetermination of the precision and reproducibility of HairDx Test in accordance with the laboratory instructions for use documentation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026